Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease

S. Majdoub Fehri (ARIANA, Tunisia)

Source: International Congress 2017 – Novel and old entities
Session: Novel and old entities
Session type: Thematic Poster
Number: 3837
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Majdoub Fehri (ARIANA, Tunisia). Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease. 3837

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006

RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients
Source: Eur Respir J 2014; 44: 1082-1085
Year: 2014


Pulmonary disease associated with rheumatoid arthritis
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021

Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010

Allergic respiratory diseases and rheumatoid arthritis
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001

Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Bronchiectasis and autoimmune disease
Source: Eur Respir Mon 2011; 52: 192-210
Year: 2011


Non-organ-specific manifestations of sarcoidosis
Source: Eur Respir Monogr 2022; 96: 206-222
Year: 2022


Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006

ANCA positivity is not associated with rheumatoid factor nor with Caplan´s syndrome in silica exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 147s
Year: 2004

Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017



Antinuclear antibodies and severe evolution of asthma
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007



Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006

Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Year: 2021



Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Are smoking and COPD associated with ILD onset in rheumatoid arthritis?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Rheumatoid arthritis-related lung disease
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Rheumatoid arthritis-associated lung disease
Source: Eur Respir Rev 2015; 24: 1-16
Year: 2015


Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Pulmonary involvement in spondilarthropathies and rheumatoid polyarthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002